Marlex Pharmaceuticals, Inc. 2023-09-13 Health serious FDA
Health · FDA · Recall #FDA-D-1170-2023
Digoxin Tablets, USP 0.25mg, 100-count bottles, Rx Only, Manufactured for/Distributed… Recall
Issued September 13, 2023 · Marlex Pharmaceuticals, Inc.
In September 2023, Marlex Pharmaceuticals, Inc. recalled the Digoxin Tablets, USP 0.25mg, 100-count bottles, Rx Only, Manufactured for/Distributed…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.
What you should do
- 1 Stop using Digoxin Tablets, USP 0.25mg, 100-count bottles, Rx Only, Manufactured for/Distributed… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Marlex Pharmaceuticals, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Marlex Pharmaceuticals, Inc.
- Category
- Health
- Recall date
- September 13, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the US.
- Recall number
- FDA-D-1170-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Marlex Pharmaceuticals, Inc. has 2 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.